Document Detail


Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.
MedLine Citation:
PMID:  15747249     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Whether the natural history of human papillomavirus (HPV) infection is affected by bacterial vaginosis (BV) or Trichomonas vaginalis (TV) infection has not been adequately investigated in prospective studies. METHODS: Human immunodeficiency virus 1 (HIV-1)-infected (n=1763) and high-risk HIV-1-uninfected (n=493) women were assessed semiannually for BV (by Nugent's criteria), TV infection (by wet mount), type-specific HPV (by polymerase chain reaction with MY09/MY11/HMB01 HPV primers), and squamous intraepithelial lesions (SIL) (by cytological examination). Sexual history was obtained from patient report at each visit. Risk factors for prevalent and incident HPV infection and SIL were evaluated by use of multivariate models. RESULTS: BV was associated with both prevalent and incident HPV infection but not with duration of HPV infection or incidence of SIL. TV infection was associated with incident HPV infection and with decreased duration and lower prevalence of HPV infection. TV infection had no association with development of SIL. Effects of BV and TV infection were similar in HIV-1-infected and high-risk HIV-1-uninfected women. HIV-1 infection and low CD4(+) lymphocyte count were strongly associated with HPV infection and development of SIL. CONCLUSIONS: BV and TV infection may increase the risk of acquisition (or reactivation) of HPV infection, as is consistent with hypotheses that the local cervicovaginal milieu plays a role in susceptibility to HPV infection. The finding that BV did not affect persistence of HPV infection and that TV infection may shorten the duration of HPV infection helps explain the lack of effect that BV and TV infection have on development of SIL.
Authors:
D Heather Watts; Melissa Fazzari; Melissa Fazarri; Howard Minkoff; Sharon L Hillier; Beverly Sha; Marshall Glesby; Alexandra M Levine; Robert Burk; Joel M Palefsky; Michael Moxley; Linda Ahdieh-Grant; Howard D Strickler
Related Documents :
17619249 - Influenza virus a (h5n1): a pandemic risk?
19526249 - Elimination of high-risk human papillomavirus type hpv16 infection by 'praneem' polyher...
21460469 - Validity of icd-9-cm coding for identifying incident methicillin-resistant staphylococc...
1850179 - Genital human papilloma virus infection in males. a clinico-pathologic study.
9217659 - Diagnosis of human papillomavirus genital tract infection.
16511749 - Environmental factors influence the rate of human herpesvirus type 8 infection in a pop...
19375629 - Histoplasmosis.
3192439 - Efficacy of febantel paste against naturally acquired gastrointestinal nematodes of cat...
15365009 - Oligonucleotide chip for detection of lamivudine-resistant hepatitis b virus.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.     Date:  2005-02-21
Journal Detail:
Title:  The Journal of infectious diseases     Volume:  191     ISSN:  0022-1899     ISO Abbreviation:  J. Infect. Dis.     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-03-04     Completed Date:  2005-05-06     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0413675     Medline TA:  J Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1129-39     Citation Subset:  AIM; IM    
Affiliation:
National Institute of Child Health and Human Development, NIH, Bethesda, Maryland 20892-7510, USA. hw59i@nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
CD4 Lymphocyte Count
Female
HIV Infections / complications*
Humans
Middle Aged
Neoplasms, Squamous Cell / epidemiology
Papillomaviridae / isolation & purification
Papillomavirus Infections / complications*,  physiopathology*
Prospective Studies
Risk Factors
Trichomonas Vaginitis / complications*
United States
Vagina / cytology,  microbiology,  parasitology,  virology
Vaginal Douching
Vaginal Smears
Vaginosis, Bacterial / complications*
Grant Support
ID/Acronym/Agency:
M01 RR00079/RR/NCRR NIH HHS; N01-AI-35161/AI/NIAID NIH HHS; R01 CA85178-01/CA/NCI NIH HHS; U01-AI-31834/AI/NIAID NIH HHS; U01-AI-34989/AI/NIAID NIH HHS; U01-AI-34993/AI/NIAID NIH HHS; U01-AI-35004/AI/NIAID NIH HHS; U01-AI-42590/AI/NIAID NIH HHS; U01-AI34994/AI/NIAID NIH HHS; U01-HD-32632/HD/NICHD NIH HHS
Comments/Corrections
Erratum In:
J Infect Dis. 2005 Sep 1;192(5):943
Note: Fazarri, Melissa [corrected to Fazzari, Melissa]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans:...
Next Document:  The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between ser...